DRGem Corp

DRGem Corp maintains a strong liquidity position with a current ratio of 3.71 and cash and equivalents of KRW 13.63 billion, indicating robust short-term financial flexibility. The company's price-to-book ratio of 0.66 and price-to-tangible-book ratio of 0.66 suggest that the market values the company below its book value, potentially reflecting conservative expectations or asset-heavy operations. The debt-to-equity ratio of 0.12 highlights a conservative capital structure with minimal leverage. Profitability metrics show a return on equity (ROE) of 7.36% and a return on assets (ROA) of 5.56%, both below the typical thresholds for high-growth healthcare equipment firms. The gross profit margin of 31.1% (KRW 32.21 billion on KRW 102.75 billion revenue) is in line with industry norms, but the operating margin of 7.82% (KRW 8.04 billion) suggests moderate operating efficiency. The company's revenue is concentrated in the domestic Korean market, with no disclosed breakdown of international sales. This geographic concentration could expose the company to regulatory and economic risks specific to South Korea. No material segment disclosures are available, but the primary business is centered on diagnostic X-ray systems and related components. Outlook data indicates a projected revenue growth of 4.2% in the current fiscal year and 3.8% in the next, driven by continued demand for digital X-ray systems and retrofit solutions. The company's free cash flow of KRW 3.39 billion supports reinvestment and shareholder returns. Risk assessment shows low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt load and strong cash position reduce financial distress risk. No dilution pressure is expected in the near term, with shares outstanding remaining stable at 10.9 million. Recent filings and transcripts do not indicate any material events or strategic shifts. The company continues to focus on its core diagnostic X-ray systems and digital upgrade solutions, with no disclosed M&A activity or major capital projects in the latest reports.